Cardiogen 20mg
Cardiac Peptide Bioregulator for Heart Tissue Research
Cardiogen is a Khavinson tetrapeptide bioregulator (Ala-Glu-Asp-Arg) that normalizes gene expression in myocardial cells, supporting cardiac tissue repair and function in aging and post-injury models.
Cardiac Peptide Bioregulator for Heart Tissue Research
Organ-specific peptide bioregulator targeting myocardial tissue to restore normal cardiomyocyte protein synthesis and support heart muscle health through epigenetic modulation.
As one of the most studied compounds in the recovery & healing research space, Cardiogen has attracted sustained scientific interest across Cardiac tissue research, Heart health studies, Aging heart biology. Peer-reviewed evidence indicates that heart-specific Khavinson bioregulator, which has positioned Cardiogen as a reference standard for researchers exploring cardiac tissue research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Cardiogen Documented Benefits: 2 Documented Mechanisms
Myocardial Support
Normalizes cardiomyocyte gene expression for cardiac tissue health and repair.
Cardiac Anti-Aging
Supports myocardial function in aging heart tissue research models.
How Cardiogen Works: Molecular Mechanism & Pathway
Organ-specific tetrapeptide modulator normalizing gene expression in myocardial cells via epigenetic pathway activation.
The 2 primary research pathways identified for Cardiogen — Myocardial Support, Cardiac Anti-Aging — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that myocardial gene expression normalization, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Cardiogen's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Cardiogen is routinely studied alongside MOTS-c and SS-31 in recovery & healing-focused compound panels. Researchers investigating cardiac tissue research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that russian pharmacopeia research compound has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Cardiogen research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Heart-specific Khavinson bioregulator
- Myocardial gene expression normalization
- Russian pharmacopeia research compound
Ideal For
- Cardiac tissue research
- Heart health studies
- Aging heart biology
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Cardiogen. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Heart-specific Khavinson bioregulator
Myocardial gene expression normalization
Russian pharmacopeia research compound
Third-Party Verified Every Batch
Each vial of Cardiogen is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
